Phase II trial of short-term neoadjuvant docetaxel and complete androgen blockade in high-risk prostate cancer
暂无分享,去创建一个
E. Gallardo | B. Mellado | P. Gascón | A. Font | J. Areal | L. Aparicio | A. Alcaraz | F. Veiga | N. Hannaoui | J. R. M. Lorenzo | A. Sousa | P. Fernández | P. Fernandez